Tradestie Institutional Equity Comparison Engine
ECOR vs EQ โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
EQ Overall Edge
EQ Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Equillium, Inc. Common Stock (EQ) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ECOR trades at N/M Forward P/E with -33.1% operating margin (+11.5% YoY revenue) versus EQ at 1.5x Forward P/E and 0.0% operating margin (-52.3% YoY). In options structure, ECOR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EQ sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
EQ
ECOR N/M vs EQ 1.5x Fwd P/E
Growth & Margin Winner
EQ
Op Margin -33.1% vs 0.0% ยท YoY +11.5% vs -52.3%
Momentum & Technical Winner
EQ
1Y -4.0% vs +12.0% ยท 52W Pos 6% vs 11%
Options & Structure Winner
EQ
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (100th %ile IV)
ECOR
NASDAQ
electroCore, Inc. Common Stock
Electromedical & Electrotherapeutic Apparatus
$4.85
-6.19% 1D
Market Cap
$47.7M
1M Return
-34.01%
1Y Return
-3.96%
Forward P/E
N/M
Unified AI Score
56.8 / 100
HOLD
Tech 68.0
Fund 53.0
Flow 50.0
Mom 64.0
EQ
NASDAQ
Equillium, Inc. Common Stock
Pharmaceutical Preparations
$1.12
+1.82% 1D
Market Cap
$90.6M
1M Return
-21.13%
1Y Return
+12.0%
Forward P/E
1.5x
Unified AI Score
48.0 / 100
HOLD
Tech 30.0
Fund 51.0
Flow 63.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ECOR -3.96%
EQ +12.0%
Spread: +15.96 pp (EQ Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ECOR Revenue | EQ Revenue | ECOR Op. Margin | EQ Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $0M | N/A | -5494.1% | N/A | ECOR |
| FY2019 | $0M | N/A | -1928.2% | N/A | ECOR |
| FY2020 | $0M | N/A | -707.9% | N/A | ECOR |
| FY2021 | $10M | N/A | -367.7% | N/A | ECOR |
| FY2022 | $10M | $20M | -266.2% | -393.9% | ECOR |
| FY2023 | $20M | $40M | -120.2% | -40.2% | EQ |
| FY2024 | $30M | $40M | -48.3% | -20.1% | EQ |
| FY2025 | $30M | N/A | -41.1% | N/A | ECOR |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ECOR | EQ | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $47.7M | $90.6M | Larger Scale | EQ |
| Trailing P/E Ratio Valuation | N/M | 1.5x | Lower Multiple | EQ |
| Forward P/E Ratio Valuation | N/M | 1.5x | Lower Multiple | EQ |
| Revenue Growth (YoY) Growth | +11.5% | -52.3% | Higher Growth | ECOR |
| Operating Margin (TTM) Profitability | -33.1% | 0.0% | Higher Margin | EQ |
| Net Profit Margin Profitability | -33.5% | 0.0% | Higher Margin | EQ |
| Return on Equity (ROE) Capital Efficiency | -478.7% | -59.0% | Higher ROE | EQ |
| 52-Week Range Position Momentum | 6% ($4โ$13) | 11% ($1โ$4) | Stronger Trend | EQ |
| Beta / 30D Volatility Risk Regime | 1.52ฮฒ ยท 155% Vol | 1.53ฮฒ ยท 93% Vol | Lower Realized Risk | EQ |
| Unified Institutional Score Composite Signal | 56.8 / 100 (HOLD) | 48.0 / 100 (HOLD) | Higher Composite | ECOR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ECOR vs EQ Buy Guide
ECOR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
EQ
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ECOR nor EQ registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.